Department of Nephrology, Second Affiliated Hospital of Soochow University, Suzhou, China.
Department of Nursing, Second Affiliated Hospital of Soochow University, Suzhou, China.
Int J Clin Pract. 2022 Mar 3;2022:6524717. doi: 10.1155/2022/6524717. eCollection 2022.
This study aimed to explore follow-up mode changes for peritoneal dialysis (PD) patients and their effects on PD quality during the COVID-19 pandemic.
A retrospective single-center study was conducted. All patients who received PD treatment at the Second Affiliated Hospital of Soochow University between January 2018 and March 2020 were enrolled in this study. Patient data during the first quarter of 2018 (Q1-2018), the first quarter of 2019 (Q1-2019), and the first quarter of 2020 (Q1-2020) were collected.
No significant differences were observed for any serum examinations in different follow-up periods ( > 0.05). A significantly reduced outpatient follow-up rate was observed in Q1-2020 compared with Q1-2018 and Q1-2019 (71.6% Vs 78.9% Vs 84.7%, < 0.001), accompanied by a significantly increased remote follow-up rate (28.4% Vs 21.1% Vs 15.3%, < 0.001). Compared with Q1-2018 and Q1-2019, the hospitalization rate (27.7% Vs 30.9% Vs 15.7%, < 0.001) and the incidence of peritonitis (0.162 Vs 0.186 Vs 0.08 per patient-year, < 0.001) decreased significantly in Q1-2020. PD patients had a significant decline in the drop-out rate for Q1-2020 compared with Q1-2019 (4.4% Vs 7.3% Vs 2.2%, < 0.001). No differences in the incidence of catheter-related infections were observed. No significant differences were observed for any peritoneal dialysis key performance indicators (KPIs) between outpatient follow-up and remote follow-up patients.
During the COVID-19 pandemic (Q1-2020), our center practiced more remote follow-up procedures in PD patients. The hospitalization rate and peritonitis incidence were significantly decreased compared with the same time in previous years. No statistical differences were observed in other KPIs for peritoneal dialysis. This study shows that telehealth methods are a reasonable alternative to in-person care in the care/management of PD patients.
本研究旨在探讨 COVID-19 大流行期间腹膜透析（PD）患者的随访模式变化及其对 PD 质量的影响。
这是一项回顾性单中心研究。纳入 2018 年 1 月至 2020 年 3 月在苏州大学附属第二医院接受 PD 治疗的所有患者。收集 2018 年第一季度（Q1-2018）、2019 年第一季度（Q1-2019）和 2020 年第一季度（Q1-2020）患者的数据。
不同随访期间的任何血清检查均无显著差异（>0.05）。与 Q1-2018 和 Q1-2019 相比，Q1-2020 门诊随访率显著降低（71.6%比 78.9%比 84.7%，<0.001），远程随访率显著升高（28.4%比 21.1%比 15.3%，<0.001）。与 Q1-2018 和 Q1-2019 相比，Q1-2020 住院率（27.7%比 30.9%比 15.7%，<0.001）和腹膜炎发生率（0.162 比 0.186 比 0.08 每患者年，<0.001）显著降低。与 Q1-2019 相比，Q1-2020 患者的脱落率显著降低（4.4%比 7.3%比 2.2%，<0.001）。导管相关性感染的发生率无差异。门诊随访和远程随访患者的任何腹膜透析关键绩效指标（KPI）均无差异。
在 COVID-19 大流行期间（Q1-2020），我们中心对 PD 患者实施了更多的远程随访程序。与前几年同期相比，住院率和腹膜炎发生率显著降低。腹膜透析的其他 KPI 无统计学差异。本研究表明，远程医疗方法是 PD 患者护理/管理中替代面对面护理的合理选择。
